Gracell Biotechnologies to Participate in Upcoming Virtual Conferences in June

Rhea-AI Summary

Gracell Biotechnologies (NASDAQ: GRCL), a clinical-stage biopharmaceutical company, announced its participation in key virtual conferences for June 2021. The company will hold one-on-one and small group meetings during the Jefferies Virtual Healthcare Conference from June 1-4, including a fireside chat on June 4 at 8:00 AM ET. Additionally, Gracell will participate in the Citi Pan-Asia Regional Investor Conference from June 2-4. These events aim to enhance communication with investors and showcase Gracell's innovative cell therapy technologies.

SUZHOU, China and PALO ALTO, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that it will participate in the following upcoming virtual conferences:

Jefferies Virtual Healthcare Conference
One-on-one and small group meetings: June 1-4, 2021
Fireside chat: June 4, 2021, 8:00 – 8:25 am ET
Webcast link: https://ir.gracellbio.com/news-events/events-and-presentations
The replay of the fireside chat can be accessed through the “News and Events” section of the Gracell Investor website.
For more information, please contact your Jefferies representative.

Citi Pan-Asia Regional Investor Conference
One-on-one and small group meetings: June 2-4, 2021
For more information, please contact your Citi representative.

About Gracell
Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal production quality, high therapy cost and lack of effective CAR-T therapies for solid tumors. For more information on Gracell, please visit www.gracellbio.com
Follow @GracellBio on LinkedIn

Media contact
Marvin Tang
marvin.tang@gracellbio.com

Investor contact
Gracie Tong
gracie.tong@gracellbio.com

FAQ

What conferences is Gracell participating in during June 2021?

Gracell is participating in the Jefferies Virtual Healthcare Conference (June 1-4) and the Citi Pan-Asia Regional Investor Conference (June 2-4).

When will Gracell hold its fireside chat at the Jefferies Conference?

The fireside chat will be held on June 4, 2021, from 8:00 to 8:25 AM ET.

Where can I access the replay of Gracell's fireside chat?

The replay can be accessed through the 'News and Events' section of the Gracell Investor website.

What is Gracell known for in the biopharmaceutical industry?

Gracell is known for developing highly efficacious and affordable cell therapies for cancer treatment using its FasTCAR and TruUCAR technology platforms.

What are the dates of the Jefferies Virtual Healthcare Conference?

The conference will take place from June 1 to June 4, 2021.